Novacyt
Develops and manufactures molecular diagnostic tests for various health markets.
ALNOV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010397232 (+1 more)
- LEI:
- 213800BWAC2BF295EG28
- Country:
- France
- Address:
- 13 AVENUE MORANE SAULNIER, 78129 VELIZY-VILLACOUBLAY
- Website:
- https://novacyt.com/
- Sector:
- Manufacturing
Description
Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-02 15:00 |
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | DOC • 218.7 KB | ||
| 2024-11-14 14:20 |
Further expansion of cost reduction programme
|
English | DOC • 26.2 KB | ||
| 2024-11-14 14:20 |
Further expansion of cost reduction programme
|
English | DOC • 244.2 KB | ||
| 2024-11-14 14:20 |
Expansion du programme de réduction des coûts
|
French | DOC • 285.7 KB | ||
| 2024-11-14 08:00 |
London Vet Show: Launch of animal multiplex assays
|
English | DOC • 26.1 KB | ||
| 2024-11-14 08:00 |
Lancement de nouveaux tests multiplexes pour animaux au London Vet Show
|
French | DOC • 236.2 KB | ||
| 2024-11-01 13:45 |
Liquidity Agreement and Total Voting Rights
|
English | DOC • 24.4 KB | ||
| 2024-11-01 13:45 |
Liquidity Agreement and Total Voting Rights
|
English | DOC • 182.4 KB | ||
| 2024-11-01 13:45 |
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | DOC • 217.9 KB | ||
| 2024-10-31 08:00 |
Directorate Change
|
English | DOC • 29.1 KB | ||
| 2024-10-31 08:00 |
Changement au Conseil d’Administration
|
French | DOC • 288.9 KB | ||
| 2024-10-31 08:00 |
Directorate Change
|
English | DOC • 245.3 KB | ||
| 2024-10-17 10:45 |
Certification IVDR obtenue pour le test de référence Yourgene® de la mucoviscid…
|
French | DOC • 308.3 KB | ||
| 2024-10-17 08:00 |
IVDR accreditation
|
English | DOC • 26.6 KB | ||
| 2024-10-08 13:30 |
Closure of IT-IS International
|
English | DOC • 24.1 KB |
Automate Your Workflow. Get a real-time feed of all Novacyt filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Novacyt
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Novacyt via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
